Bistability in fatty-acid oxidation resulting from substrate inhibition.

In this study we demonstrated through analytic considerations and numerical studies that the mitochondrial fatty-acid β-oxidation can exhibit bistable-hysteresis behavior. In an experimentally validated computational model we identified a specific region in the parameter space in which two distinct...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fentaw Abegaz, Anne-Claire M F Martines, Marcel A Vieira-Lara, Melany Rios-Morales, Dirk-Jan Reijngoud, Ernst C Wit, Barbara M Bakker
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
Acceso en línea:https://doaj.org/article/febc2d2c3e1e4399b08b47a1554814cc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:febc2d2c3e1e4399b08b47a1554814cc
record_format dspace
spelling oai:doaj.org-article:febc2d2c3e1e4399b08b47a1554814cc2021-12-02T19:58:06ZBistability in fatty-acid oxidation resulting from substrate inhibition.1553-734X1553-735810.1371/journal.pcbi.1009259https://doaj.org/article/febc2d2c3e1e4399b08b47a1554814cc2021-08-01T00:00:00Zhttps://doi.org/10.1371/journal.pcbi.1009259https://doaj.org/toc/1553-734Xhttps://doaj.org/toc/1553-7358In this study we demonstrated through analytic considerations and numerical studies that the mitochondrial fatty-acid β-oxidation can exhibit bistable-hysteresis behavior. In an experimentally validated computational model we identified a specific region in the parameter space in which two distinct stable and one unstable steady state could be attained with different fluxes. The two stable states were referred to as low-flux (disease) and high-flux (healthy) state. By a modular kinetic approach we traced the origin and causes of the bistability back to the distributive kinetics and the conservation of CoA, in particular in the last rounds of the β-oxidation. We then extended the model to investigate various interventions that may confer health benefits by activating the pathway, including (i) activation of the last enzyme MCKAT via its endogenous regulator p46-SHC protein, (ii) addition of a thioesterase (an acyl-CoA hydrolysing enzyme) as a safety valve, and (iii) concomitant activation of a number of upstream and downstream enzymes by short-chain fatty-acids (SCFA), metabolites that are produced from nutritional fibers in the gut. A high concentration of SCFAs, thioesterase activity, and inhibition of the p46Shc protein led to a disappearance of the bistability, leaving only the high-flux state. A better understanding of the switch behavior of the mitochondrial fatty-acid oxidation process between a low- and a high-flux state may lead to dietary and pharmacological intervention in the treatment or prevention of obesity and or non-alcoholic fatty-liver disease.Fentaw AbegazAnne-Claire M F MartinesMarcel A Vieira-LaraMelany Rios-MoralesDirk-Jan ReijngoudErnst C WitBarbara M BakkerPublic Library of Science (PLoS)articleBiology (General)QH301-705.5ENPLoS Computational Biology, Vol 17, Iss 8, p e1009259 (2021)
institution DOAJ
collection DOAJ
language EN
topic Biology (General)
QH301-705.5
spellingShingle Biology (General)
QH301-705.5
Fentaw Abegaz
Anne-Claire M F Martines
Marcel A Vieira-Lara
Melany Rios-Morales
Dirk-Jan Reijngoud
Ernst C Wit
Barbara M Bakker
Bistability in fatty-acid oxidation resulting from substrate inhibition.
description In this study we demonstrated through analytic considerations and numerical studies that the mitochondrial fatty-acid β-oxidation can exhibit bistable-hysteresis behavior. In an experimentally validated computational model we identified a specific region in the parameter space in which two distinct stable and one unstable steady state could be attained with different fluxes. The two stable states were referred to as low-flux (disease) and high-flux (healthy) state. By a modular kinetic approach we traced the origin and causes of the bistability back to the distributive kinetics and the conservation of CoA, in particular in the last rounds of the β-oxidation. We then extended the model to investigate various interventions that may confer health benefits by activating the pathway, including (i) activation of the last enzyme MCKAT via its endogenous regulator p46-SHC protein, (ii) addition of a thioesterase (an acyl-CoA hydrolysing enzyme) as a safety valve, and (iii) concomitant activation of a number of upstream and downstream enzymes by short-chain fatty-acids (SCFA), metabolites that are produced from nutritional fibers in the gut. A high concentration of SCFAs, thioesterase activity, and inhibition of the p46Shc protein led to a disappearance of the bistability, leaving only the high-flux state. A better understanding of the switch behavior of the mitochondrial fatty-acid oxidation process between a low- and a high-flux state may lead to dietary and pharmacological intervention in the treatment or prevention of obesity and or non-alcoholic fatty-liver disease.
format article
author Fentaw Abegaz
Anne-Claire M F Martines
Marcel A Vieira-Lara
Melany Rios-Morales
Dirk-Jan Reijngoud
Ernst C Wit
Barbara M Bakker
author_facet Fentaw Abegaz
Anne-Claire M F Martines
Marcel A Vieira-Lara
Melany Rios-Morales
Dirk-Jan Reijngoud
Ernst C Wit
Barbara M Bakker
author_sort Fentaw Abegaz
title Bistability in fatty-acid oxidation resulting from substrate inhibition.
title_short Bistability in fatty-acid oxidation resulting from substrate inhibition.
title_full Bistability in fatty-acid oxidation resulting from substrate inhibition.
title_fullStr Bistability in fatty-acid oxidation resulting from substrate inhibition.
title_full_unstemmed Bistability in fatty-acid oxidation resulting from substrate inhibition.
title_sort bistability in fatty-acid oxidation resulting from substrate inhibition.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/febc2d2c3e1e4399b08b47a1554814cc
work_keys_str_mv AT fentawabegaz bistabilityinfattyacidoxidationresultingfromsubstrateinhibition
AT anneclairemfmartines bistabilityinfattyacidoxidationresultingfromsubstrateinhibition
AT marcelavieiralara bistabilityinfattyacidoxidationresultingfromsubstrateinhibition
AT melanyriosmorales bistabilityinfattyacidoxidationresultingfromsubstrateinhibition
AT dirkjanreijngoud bistabilityinfattyacidoxidationresultingfromsubstrateinhibition
AT ernstcwit bistabilityinfattyacidoxidationresultingfromsubstrateinhibition
AT barbarambakker bistabilityinfattyacidoxidationresultingfromsubstrateinhibition
_version_ 1718375819476205568